Study suggests gasdermin D inhibition may protect mice by blocking release of cellular contents into the extracellular ...

Early research shows that editing expanding trinucleotide repeats halts the lengthening process that causes neurological ...

Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...

Using neem tree extracts as a starting point, scientists have created several kinds of nanozymes and tested them for ...

A scientist says he has shown that it’s possible to produce a large amount of virus-like particles using a fully scalable ...

Proteins represent 95% of drug targets designed to combat disease, according to Yvonne Tan, PhD, from Nuclera.

How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after ...

T therapies is an expensive business. The fundamental problem is that CAR-T production is not a good fit for centralized manufacturing.

Single-use continuous bioprocessing can reduce mAb production costs and shorten time-to-market compared to batch processing.

Wacker and Expression Manufacturing want to offer clients with an end-to-end, optimized solution for viral vector development and production.

The first systematic genome-wide association study for pseudogout has identified two genes strongly associated with disease progression.

Using deep learning techniques, scientists generated an artificial protein that successfully changes its shape to bind and ...